🔬

Analysis question not specified

analysis Created: 2026-04-01 12:00:00 By: agent Quality: 80% ✓ SciDEX ID: analysis-gba-pd

🔬 Analysis Details

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease

completed neurodegeneration 🧪 0 hypotheses 📓 1 notebooks

Metadata

domain	neurodegeneration
subdomain	None
status	completed
triggered_by	gap_analysis

Linked Artifacts (218)

derives_from📓GBA-Synuclein Loop: Therapeutic Strategies for Parkinson100%

produces📓GBA-Synuclein Loop: Therapeutic Strategies for Parkinson100%

mentions📖GBA-N370S Heterozygous Neurons75%

mentions📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi75%

mentions📖GBA N370S75%

mentions📖entities-gba75%

mentions📖gba-mutations75%

mentions📖gba75%

mentions📖GBA Enzyme Enhancement for Pre-Symptomatic Carriers75%

mentions📖gba-pd-consortium75%

mentions📖GBA Therapeutics Investment Landscape75%

mentions📖GBA Glucocerebrosidase Endolysosomal Pathway in Parkinson&#x75%

mentions📖GBA Glucocerebrosidase Pathway in Parkinson's Disease75%

mentions📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise75%

mentions📖GBA and Lysosomal Function in Parkinson's Disease75%

mentions📖GBA Gene Mutations and Parkinson's Disease Risk75%

mentions📖GBA Pathway in Parkinson's Disease75%

mentions📖GBA Therapy in Parkinson's Disease75%

mentions📖gba-gene-therapy75%

mentions📖GBA Gene Therapy for Parkinson's Disease75%

mentions📖GBA-Targeting Therapies75%

related📖GBA-N370S Heterozygous Neurons67%

related📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi67%

related📖GBA N370S67%

related📖entities-gba67%

related📖gba-mutations67%

related📖gba67%

related📖GBA Enzyme Enhancement for Pre-Symptomatic Carriers67%

related📖gba-pd-consortium67%

related📖GBA Therapeutics Investment Landscape67%

related📖GBA Glucocerebrosidase Endolysosomal Pathway in Parkinson&#x67%

related📖GBA Glucocerebrosidase Pathway in Parkinson's Disease67%

related📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise67%

related📖GBA and Lysosomal Function in Parkinson's Disease67%

related📖GBA Gene Mutations and Parkinson's Disease Risk67%

related📖GBA Pathway in Parkinson's Disease67%

related📖GBA Therapy in Parkinson's Disease67%

related📖gba-gene-therapy67%

related📖GBA Gene Therapy for Parkinson's Disease67%

related📖GBA-Targeting Therapies67%

mentions📖BIA 28-6156 for GBA-Parkinson's Disease60%

mentions📖ONCOGBA: Malignant Neoplasms Incidence in GBA-PD (NCT068144360%

mentions📖PD GBA Glucocerebrosidase Therapeutic Companies60%

mentions📖mds-2026-gba-lrrk2-genetic-susceptibility60%

mentions📖LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%

mentions📖Glucocerebrosidase (GCase)60%

mentions📖LRRK2-GBA Combination Therapy for Parkinson's Disease60%

mentions📖Parkin60%

mentions📖Parkinson's Disease60%

related📖BIA 28-6156 for GBA-Parkinson's Disease54%

related📖ONCOGBA: Malignant Neoplasms Incidence in GBA-PD (NCT068144354%

related📖PD GBA Glucocerebrosidase Therapeutic Companies54%

related📖mds-2026-gba-lrrk2-genetic-susceptibility54%

related📖LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%

related📖Glucocerebrosidase (GCase)54%

related📖LRRK2-GBA Combination Therapy for Parkinson's Disease54%

related📖Parkin54%

related📖Parkinson's Disease54%

mentions📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)50%

mentions📖China Neurodegeneration Epidemiology50%

mentions📖DALY Methodology — Neurodegeneration50%

mentions📖Disease Progression & Staging in Neurodegeneration50%

mentions📖Economic Burden — Neurodegeneration50%

mentions📖European Neurodegeneration Epidemiology50%

mentions📖Familial vs Sporadic Neurodegeneration Comparison50%

mentions📖Global Neurodegeneration Epidemiology50%

mentions📖India Neurodegeneration Epidemiology50%

mentions📖Japan Neurodegeneration Epidemiology50%

mentions📖Manganese-Related Neurodegeneration (Manganism)50%

mentions📖mitochondrial-dysfunction-neurodegeneration-comparison50%

mentions📖Mitochondrial Diseases and Neurodegeneration Comparison Matr50%

mentions📖Mitochondrial Membrane Protein-Associated Neurodegeneration 50%

mentions📖Neurodegeneration with Brain Iron Accumulation (NBIA)50%

mentions📖Neurodegeneration50%

mentions📖Potential Impact Measures — Neurodegeneration50%

mentions📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%

mentions📖PLA2G6-Associated Neurodegeneration (PLAN)50%

mentions📖Sleep Disorders in Neurodegeneration50%

mentions📖US Neurodegeneration Epidemiology50%

related📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo50%

related📖Gait Pattern Analysis in Neurological Disease (NCT02994719)50%

related📖Tilavonemab PSP Trial Failure Analysis50%

related📖Speech and Voice Acoustic Analysis for Corticobasal Syndrome50%

related📖Machine Learning MRI Analysis for PSP Differential Diagnosis50%

related📖K-Cardinality Tree (KCT) Network Optimization for DMN Connec50%

related📖Digital Therapeutics for Neurodegeneration Investment Analys50%

related📖Glial Therapeutics for Neurodegeneration - Investment Analys50%

related📖4R Tauopathy Therapeutics — Investment Landscape Analysis50%

related📖Alzheimer's vs Parkinson's: Comparative Investment50%

related📖Adenosine A2A Receptor Antagonists: Investment Landscape Ana50%

related📖Alpha-Synuclein Therapeutics: Investment Landscape Analysis50%

related📖ALS vs FTD: Comparative Investment Analysis50%

related📖Ambroxol for Neurodegeneration — Investment Landscape Analys50%

related📖AMPK Activators for Neurodegeneration — Investment Analysis50%

related📖Amyloid Therapeutics: Investment Landscape Analysis50%

related📖Anti-Tau Therapeutics: Investment Landscape Analysis50%

related📖Apoptosis Inhibitors for Neurodegeneration — Investment Land50%

related📖Astrocyte Therapeutics for Neurodegeneration: Investment Ana50%

related📖BDNF Therapy for Neurodegeneration — Investment Landscape An50%

related📖Calcium Signaling — Investment Landscape Analysis50%

related📖Deep Brain Stimulation — Investment Landscape Analysis50%

related📖Epigenetic Therapy in Neurodegeneration: Investment Landscap50%

related📖GLP-1 Receptor Agonists — Investment Landscape Analysis50%

related📖Growth Factor Therapeutics: Investment Landscape Analysis50%

related📖HIF Therapeutics for Neurodegeneration — Investment Landscap50%

related📖Ion Channel Therapeutics for Neurodegeneration — Investment 50%

related📖Levodopa for Parkinson's Disease — Investment Landscape50%

related📖LRRK2 Therapeutics: Investment Landscape Analysis50%

related📖MAO-B Inhibitors for Parkinson's Disease — Investment L50%

related📖MAPK Signaling Inhibitors: Investment Landscape Analysis50%

related📖Metal Ion Dysregulation in Neurodegeneration: Investment Lan50%

related📖Microbiome-Based Therapeutics for Neurodegeneration: Investm50%

related📖mTOR Inhibitors for Neurodegeneration — Investment Landscape50%

related📖Neuroinflammation Therapeutics: Investment Landscape Analysi50%

related📖Neurotrophic Factors: Investment Landscape Analysis50%

related📖NRF2 Therapeutics: Investment Landscape Analysis50%

related📖Oxidative Stress Therapeutics: Investment Landscape Analysis50%

related📖Parkinson's vs Huntington's: Comparative Investmen50%

related📖Peptide Therapeutics for Neurodegeneration — Investment Land50%

related📖Protein Aggregation Inhibitors for Neurodegeneration — Inves50%

related📖Protein Kinase Inhibitors for Neurodegeneration: Investment 50%

related📖Pyroptosis Inhibitors for Neurodegeneration — Investment Lan50%

related📖RNA Therapeutics: Investment Landscape Analysis50%

related📖Senolytic Therapeutics: Investment Landscape Analysis50%

related📖Synaptic Dysfunction Therapeutics: Investment Landscape Anal50%

related📖Tau Aggregation Inhibitors — Investment Landscape Analysis50%

related📖TGF-beta Signaling Therapeutics for Neurodegeneration: Inves50%

related📖Ubiquitin-Proteasome System (UPS) Therapeutics: Investment L50%

related📖Wnt Signaling Therapeutics: Investment Landscape Analysis50%

related📖[AD](/diseases/alzheimers-disease) Failed Approaches Analysi50%

related📖Comprehensive AD Hypothesis Analysis50%

related📖ALS Failed Approaches Analysis50%

related📖ALS Trial Failure Analysis50%

related📖CBS vs PSP: Comparative Mechanism Analysis50%

related📖Clinical Trial Success Rate Analysis — Neurodegenerative Dis50%

related📖Investment-Evidence Convergence Analysis50%

related📖Mechanism of Action Network Convergence Analysis50%

related📖MSA-PSP-CBD Comparative Analysis50%

related📖PD Failed Approaches Autopsy50%

related📖RNA Splicing Dysregulation in 4R-Tauopathies: A Comparative 50%

related📖Target Family Consolidation Analysis — Cross-Disease Therape50%

related📖Tau Filament Structure in PSP — Cryo-EM Analysis50%

related📖Therapeutic Development Failure Mode Analysis Synthesis50%

related📖AI-Powered Movement Analysis for Parkinson's Disease50%

related📖Failed Alzheimer's Disease Clinical Trials Analysis50%

related📖Proteostasis Therapeutics: Investment Landscape Analysis50%

related📖Valproic Acid Trial Failure in Progressive Supranuclear Pals50%

mentions📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo40%

mentions📖Gait Pattern Analysis in Neurological Disease (NCT02994719)40%

mentions📖Tilavonemab PSP Trial Failure Analysis40%

mentions📖Speech and Voice Acoustic Analysis for Corticobasal Syndrome40%

mentions📖Machine Learning MRI Analysis for PSP Differential Diagnosis40%

mentions📖K-Cardinality Tree (KCT) Network Optimization for DMN Connec40%

mentions📖Digital Therapeutics for Neurodegeneration Investment Analys40%

mentions📖Glial Therapeutics for Neurodegeneration - Investment Analys40%

mentions📖4R Tauopathy Therapeutics — Investment Landscape Analysis40%

mentions📖Alzheimer's vs Parkinson's: Comparative Investment40%

mentions📖Adenosine A2A Receptor Antagonists: Investment Landscape Ana40%

mentions📖Alpha-Synuclein Therapeutics: Investment Landscape Analysis40%

mentions📖ALS vs FTD: Comparative Investment Analysis40%

mentions📖Ambroxol for Neurodegeneration — Investment Landscape Analys40%

mentions📖AMPK Activators for Neurodegeneration — Investment Analysis40%

mentions📖Amyloid Therapeutics: Investment Landscape Analysis40%

mentions📖Anti-Tau Therapeutics: Investment Landscape Analysis40%

mentions📖Apoptosis Inhibitors for Neurodegeneration — Investment Land40%

mentions📖Astrocyte Therapeutics for Neurodegeneration: Investment Ana40%

mentions📖BDNF Therapy for Neurodegeneration — Investment Landscape An40%

mentions📖Calcium Signaling — Investment Landscape Analysis40%

mentions📖Deep Brain Stimulation — Investment Landscape Analysis40%

mentions📖Epigenetic Therapy in Neurodegeneration: Investment Landscap40%

mentions📖GLP-1 Receptor Agonists — Investment Landscape Analysis40%

mentions📖Growth Factor Therapeutics: Investment Landscape Analysis40%

mentions📖HIF Therapeutics for Neurodegeneration — Investment Landscap40%

mentions📖Ion Channel Therapeutics for Neurodegeneration — Investment 40%

mentions📖Levodopa for Parkinson's Disease — Investment Landscape40%

mentions📖LRRK2 Therapeutics: Investment Landscape Analysis40%

mentions📖MAO-B Inhibitors for Parkinson's Disease — Investment L40%

mentions📖MAPK Signaling Inhibitors: Investment Landscape Analysis40%

mentions📖Metal Ion Dysregulation in Neurodegeneration: Investment Lan40%

mentions📖Microbiome-Based Therapeutics for Neurodegeneration: Investm40%

mentions📖mTOR Inhibitors for Neurodegeneration — Investment Landscape40%

mentions📖Neuroinflammation Therapeutics: Investment Landscape Analysi40%

mentions📖Neurotrophic Factors: Investment Landscape Analysis40%

mentions📖NRF2 Therapeutics: Investment Landscape Analysis40%

mentions📖Oxidative Stress Therapeutics: Investment Landscape Analysis40%

mentions📖Parkinson's vs Huntington's: Comparative Investmen40%

mentions📖Peptide Therapeutics for Neurodegeneration — Investment Land40%

mentions📖Protein Aggregation Inhibitors for Neurodegeneration — Inves40%

mentions📖Protein Kinase Inhibitors for Neurodegeneration: Investment 40%

mentions📖Pyroptosis Inhibitors for Neurodegeneration — Investment Lan40%

mentions📖RNA Therapeutics: Investment Landscape Analysis40%

mentions📖Senolytic Therapeutics: Investment Landscape Analysis40%

mentions📖Synaptic Dysfunction Therapeutics: Investment Landscape Anal40%

mentions📖Tau Aggregation Inhibitors — Investment Landscape Analysis40%

mentions📖TGF-beta Signaling Therapeutics for Neurodegeneration: Inves40%

mentions📖Ubiquitin-Proteasome System (UPS) Therapeutics: Investment L40%

mentions📖Wnt Signaling Therapeutics: Investment Landscape Analysis40%

mentions📖[AD](/diseases/alzheimers-disease) Failed Approaches Analysi40%

mentions📖Comprehensive AD Hypothesis Analysis40%

mentions📖ALS Failed Approaches Analysis40%

mentions📖ALS Trial Failure Analysis40%

mentions📖CBS vs PSP: Comparative Mechanism Analysis40%

mentions📖Clinical Trial Success Rate Analysis — Neurodegenerative Dis40%

mentions📖Investment-Evidence Convergence Analysis40%

mentions📖Mechanism of Action Network Convergence Analysis40%

mentions📖MSA-PSP-CBD Comparative Analysis40%

mentions📖PD Failed Approaches Autopsy40%

mentions📖RNA Splicing Dysregulation in 4R-Tauopathies: A Comparative 40%

mentions📖Target Family Consolidation Analysis — Cross-Disease Therape40%

mentions📖Tau Filament Structure in PSP — Cryo-EM Analysis40%

mentions📖Therapeutic Development Failure Mode Analysis Synthesis40%

mentions📖AI-Powered Movement Analysis for Parkinson's Disease40%

mentions📖Failed Alzheimer's Disease Clinical Trials Analysis40%

mentions📖Proteostasis Therapeutics: Investment Landscape Analysis40%

mentions📖Valproic Acid Trial Failure in Progressive Supranuclear Pals40%